Stephen J Ruberg (Stephen Ruberg)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 11

Top Venues

Nature reviews. Drug discovery

Biometrical journal. Biometrische Zeitschrift

Pharmaceutical statistics

Analytix Thinking LLC

University of Cincinnati (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Analytix Thinking LLC Jan 16 2018

United States

President

Eli Lilly and Company Mar 27 2000 - Dec 31 2017

United States

Distinguished Research Fellow :: Global Statistical Sciences

Education History

University of Cincinnati

United States

PHD :: Epidemiology & Biostatistics

Miami University Aug 20 1978 - May 11 1980

United States

MSC :: Statistics

Publications

Stephen J Ruberg, Ying Zhang, Hollins Showalter, Lei Shen
A platform for comparing subgroup identification methodologies. Biometrical journal. Biometrische Zeitschrift (2023)
Stephen J Ruberg, Ying Zhang, Hollins Showalter, Lei Shen
A platform for comparing subgroup identification methodologies. Biometrical journal. Biometrische Zeitschrift (2023)
Stephen J Ruberg, Francois Beckers, Rob Hemmings, Peter Honig, Telba Irony, Lisa M LaVange, Grazyna Lieberman, James Mayne, Richard Moscicki
Application of Bayesian approaches in drug development: starting a virtuous cycle. Nature reviews. Drug discovery (2023)
Stephen J Ruberg, Francois Beckers, Rob Hemmings, Peter Honig, Telba Irony, Lisa M LaVange, Grazyna Lieberman, James Mayne, Richard Moscicki
Application of Bayesian approaches in drug development: starting a virtuous cycle. Nature reviews. Drug discovery 22 (3) (2023)
Stephen J Ruberg, Francois Beckers, Rob Hemmings, Peter Honig, Telba Irony, Lisa M LaVange, Grazyna Lieberman, James Mayne, Richard Moscicki
Application of Bayesian approaches in drug development: starting a virtuous cycle. Nature reviews. Drug discovery 22 (3) (2023)
Ahmad Hakeem Abdul Wahab, Yongming Qu, Hege Michiels, Junxiang Luo, Run Zhuang, Dominique McDaniel, Dong Xi, Elena Polverejan, Steven Gilbert, Stephen J Ruberg, Arman Sabbaghi
CITIES: Clinical trials with intercurrent events simulator. Biometrical journal. Biometrische Zeitschrift (2023)
Stephen J Ruberg, Francois Beckers, Rob Hemmings, Peter Honig, Telba Irony, Lisa M LaVange, Grazyna Lieberman, James Mayne, Richard Moscicki
Application of Bayesian approaches in drug development: starting a virtuous cycle. Nature reviews. Drug discovery 22 (3) (2023)
Stephen J Ruberg, Francois Beckers, Rob Hemmings, Peter Honig, Telba Irony, Lisa M LaVange, Grazyna Lieberman, James Mayne, Richard Moscicki
Application of Bayesian approaches in drug development: starting a virtuous cycle. Nature reviews. Drug discovery (2023)
Stephen J Ruberg
Assessing and communicating heterogeneity of treatment effects for patient subpopulations: The hardest problem there is. Pharmaceutical statistics 20 (5) (2021)
Junxiang Luo, Stephen J Ruberg, Yongming Qu
Estimating the treatment effect for adherers using multiple imputation. Pharmaceutical statistics 21 (3) (2021)
Mark Rothmann, William H Crown, Thomas A Louis, Thomas Permutt, Stephen J Ruberg, Jodi Segal, John Scott
Assessing and communicating heterogeneity of treatment effects for patient subpopulations: Panel discussion on considerations in design and analysis. Pharmaceutical statistics 20 (5) (2020)

Stephen J Ruberg.css-eqlu8i{font-size:small;padding-left:4px;} (Stephen Ruberg)

Publication Activity (10 Years)

Top Topics

Top Venues

Stephen J Ruberg (Stephen Ruberg)